According to bioMérieux's latest financial reports the company has $0.59 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.59 B | -34.96% |
2021-12-31 | $0.90 B | 90.09% |
2020-12-31 | $0.47 B | 55.39% |
2019-12-31 | $0.30 B | -3.86% |
2018-12-31 | $0.32 B | -14.48% |
2017-12-31 | $0.37 B | 99.28% |
2016-12-31 | $0.18 B | 16.89% |
2015-12-31 | $0.16 B | 10.48% |
2014-12-31 | $0.14 B | -75.37% |
2013-12-31 | $0.59 B | 581.16% |
2012-12-31 | $86.77 M | 56.8% |
2011-12-31 | $55.33 M | -41.73% |
2010-12-31 | $94.97 M | 41.04% |
2009-12-31 | $67.33 M | -8.77% |
2008-12-31 | $73.81 M | -7.24% |
2007-12-31 | $79.57 M | 77.58% |
2006-12-31 | $44.81 M | 81.44% |
2005-12-31 | $24.69 M |